Based on the results of our study, a minimum set of analyses composed of hemocytometry plus CRP should be performed in obstetric patients with COVID-19 at admission and during hospitalization, to assess disease severity and follow the evolution of the disease. This evidence concerns the gene CRP and COVID-19.